A London judge in February 2019 ruled that a European Union agency, the European Medicines Agency (EMA), could not use Brexit to break its lease. The EMA is moving its 900-people headquarters to Amsterdam, The Netherlands as a direct result of Brexit. It has a 25-year lease for 10 floors in a building in London’s Eastern financial district, Canary Wharf, with 21 years to run. The European agency pays